within Pharmacolibrary.Drugs.ATC.N;

model N05CD09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.71,
    Cl             = 1.36 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.25 / 1000000,
    adminCount     = 1,
    Vd             = 0.00061,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Brotizolam is a short-acting thienotriazolodiazepine, a benzodiazepine derivative, mainly used as a hypnotic for the short-term treatment of severe insomnia. It has potent sedative and anxiolytic properties. Brotizolam is approved for clinical use in a number of countries, including Japan and some European countries, but is not approved in the United States or Canada.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers (both sexes), typically fasted, who received oral administration.</p><h4>References</h4><ol><li><p>Jochemsen, R, et al., &amp; Breimer, DD (1983). Pharmacokinetics of oral brotizolam in patients with liver cirrhosis. <i>British journal of clinical pharmacology</i> 16 Suppl 2(Suppl 2) 315S–322S. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1983.tb02306.x&quot;>10.1111/j.1365-2125.1983.tb02306.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6661377/&quot;>https://pubmed.ncbi.nlm.nih.gov/6661377</a></p></li><li><p>Jochemsen, R, et al., &amp; Breimer, DD (1983). Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration. <i>British journal of clinical pharmacology</i> 16 Suppl 2(Suppl 2) 285S–290S. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1983.tb02302.x&quot;>10.1111/j.1365-2125.1983.tb02302.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6661374/&quot;>https://pubmed.ncbi.nlm.nih.gov/6661374</a></p></li><li><p>Osanai, T, et al., &amp; Kaneko, S (2004). Effect of itraconazole on the pharmacokinetics and pharmacodynamics of a single oral dose of brotizolam. <i>British journal of clinical pharmacology</i> 58(5) 476–481. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.2004.02208.x&quot;>10.1111/j.1365-2125.2004.02208.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15521894/&quot;>https://pubmed.ncbi.nlm.nih.gov/15521894</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05CD09;
